The incidence of distant-stage cervical cancer in the United States increased by 1.3% per year from 2001 to 2018.
Researchers analyzed data from more than 1 million women to determine if screening intervals could be safely extended with negative human papillomavirus tests compared with negative cytology screen results.
A meta-analysis sought to determine the rates of late-stage presentation among women with cervical cancer.
Odds of ever undergoing pap testing lower for non-Hispanic White and Hispanic SM participants versus non-Hispanic White heterosexuals.
An analysis of data from Mississippi sought to determine the rate of HPV infection and mortality from cervical cancer among women by race.